15+ years of expertise

Dr. Mustafa Solak

Specialist Oncologist

MBBS from Hacettepe University Faculty of Medicine,Turkey    |Hisar Hospital

About Dr. Mustafa Solak

  • He is a highly regarded Medical Oncologist at Istanbul's Hisar Intercontinental Hospital.
  • He earned his medical degree from Hacettepe University's Faculty of Medicine and continued his education at Istanbul's iลŸli Etfal Training and Research Hospital.
  • Following that, he completed training in Minor Specialties at Hacettepe University's Cancer Institute.
  • He has a special interest in Testicular Cancer, Ovarian Cancer, Lung cancer, Head and Neck Cancers, Digestive System Cancers

Education

  • MBBS from Hacettepe University Faculty of Medicine,Turkey
  • MS from ฤฐstanbul ลžiลŸli Etfal Training and Research Hospital,Turkey

Experience

  • Dr. Mustafa Solak has over 20 years of experience in Medical Oncology (2004โ€“Present), specializing in the diagnosis and treatment of a wide range of cancers.
  • He currently works as a Medical Oncologist at Hisar Hospital Intercontinental in Istanbul, Turkey (2015โ€“Present), providing comprehensive cancer care including chemotherapy and targeted therapies.
  • He served as a Consultant Oncologist at the University of Texas MD Anderson Cancer Center (2010โ€“2015), gaining advanced experience in complex cancer treatment.
  • He worked as a Consultant Oncologist at Hitit University ร‡orum Training Hospital (2008โ€“2010), managing a broad spectrum of cancer cases.
  • He also practiced as a Consultant Oncologist at Medical Park Hospital (2004โ€“2008), contributing to multidisciplinary oncology care.

Leading Specialists in Oncology

Browse top Oncology doctors specializing in diagnostics, advanced procedures, and personalized treatment approaches.

Frequently Asked Question

He is a Specialist Oncologist from Turkey with expertise in advanced cancer treatments.

He is experienced in Tomotherapy, IMRT, IGRT, chemotherapy, targeted therapy, and immunotherapy.

He focuses on breast cancer, lung cancer, prostate cancer, and gastrointestinal cancers.